NIH Guide for Grants and Contracts
May 20, 2022
Weekly NIH Funding Opportunities and Notices
General Notices
Notice of Pre-application Webinar for NCI Funding Opportunity Announcement for RFA-CA-22-027 Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)"
(NOT-CA-22-087)
National Cancer Institute
Notice of Changes to Funding Opportunities
Notice to update Scored Review Criteria for PAR-22-108 "Innovative Ways to Provide Education on Antimicrobial Stewardship Practices in Animals (U01) Clinical Trial Not Allowed"
(NOT-FD-22-010)
Food and Drug Administration
Notice of Change in Application Due Date for RFA-HL-21-013 "Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)"
(NOT-HL-22-023)
National Heart, Lung, and Blood Institute
Notices of Intent to Publish
Notice of Intent to Publish a Funding Opportunity Announcement for Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed)
(NOT-AI-22-051)
National Institute of Allergy and Infectious Diseases
Notices of Special Interest
Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
(NOT-OD-22-126)
Office of the Director, NIH
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver
National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
Funding Opportunities
Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required)
(RFA-DA-23-008)
National Institute on Drug Abuse
Application Receipt Date(s): November 12, 2024
Expanding Prevention Strategies for Mental Disorders in Mobile Populations in Humanitarian Crises (R34 Clinical Trial Optional)
(RFA-MH-22-180)
National Institute of Mental Health
Application Receipt Date(s): October 25, 2022
NINDS Interdisciplinary Team Science Grant (RM1 Clinical Trial Optional)
(RFA-NS-22-036)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): October 08, 2024
Treatments for Lewy Body Dementias and Frontotemporal Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required)
(RFA-NS-22-056)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): November 21, 2022
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed)
(RFA-NS-22-066)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): July 28, 2022